Biblio
Export 1161 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is W [Clear All Filters]
“Risk of Dementia in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies.”, J Alzheimers Dis, vol. 89, no. 1, pp. 367-380, 2022.
, “Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
, “Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells.”, J Alzheimers Dis, vol. 90, no. 1, pp. 185-198, 2022.
, “Serum Levels of α-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1471-1481, 2022.
, “Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1831-1848, 2022.
, “Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1831-1848, 2022.
, “Single Nucleus Transcriptome Data from Alzheimer's Disease Mouse Models Yield New Insight into Pathophysiology.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1233-1247, 2022.
, “The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals.”, J Alzheimers Dis, vol. 91, no. 2, pp. 683-695, 2022.
, “40 Hz Light Flicker Promotes Learning and Memory via Long Term Depression in Wild-Type Mice.”, J Alzheimers Dis, vol. 84, no. 3, pp. 983-993, 2021.
, “Accelerometer-Measured, Habitual Physical Activity and Circulating Brain-Derived Neurotrophic Factor: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 85, no. 2, pp. 805-814, 2021.
, “Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.”, J Alzheimers Dis, vol. 83, no. 1, pp. 423-433, 2021.
, “ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.”, J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.
, “ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.”, J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.
, “Automatic Subtyping of Individuals with Primary Progressive Aphasia.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1185-1194, 2021.
, “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
, “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
, “Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer's Disease Brain Tissues.”, J Alzheimers Dis, vol. 85, no. 2, pp. 889-903, 2021.
, “Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia.”, J Alzheimers Dis, vol. 82, no. 2, pp. 781-790, 2021.
, “Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial.”, J Alzheimers Dis, vol. 80, no. 1, pp. 233-244, 2021.
, “Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1703-1715, 2021.
, “Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1703-1715, 2021.
, “Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.”, J Alzheimers Dis, vol. 83, no. 1, pp. 23-41, 2021.
, “A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1149-1159, 2021.
, “A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1149-1159, 2021.
, “A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1149-1159, 2021.
,